Prostate-Specific Antigen Improves the Ability of Clinical Stage and Biopsy Gleason Sum to Predict the Pathologic Stage at Radical Prostatectomy in the New Millennium
β Scribed by Felix K.-H. Chun; Alberto Briganti; Andrea Gallina; Georg C. Hutterer; Shahrokh F. Shariat; Elie Antebie; Jochen Walz; Claus G. Roehrborn; Andrea Salonia; Patrizio Rigatti; Fred Saad; Hartwig Huland; Francesco Montorsi; Markus Graefen; Pierre I. Karakiewicz
- Book ID
- 113609960
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 389 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0302-2838
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
prostate carcinomas with stage at radical prostatectomy (RP) and progression after RP. For the former group, 109 RP specimens with Gleason sums of 6 and 7 were
Study Type β Diagnostic (exploratory cohort) Level of Evidenceβ2b **What's known on the subject? and What does the study add?** Due to sampling error, the Gleason score of clinically localized prostate cancer is frequently underestimated at the time of initial biopsy. Given that this may lead to